These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 29246359)
1. 50 Years Ago in The Journal of Pediatrics: Editorial Comment: Therapeutic Orphans. Ross LF J Pediatr; 2018 Jan; 192():59. PubMed ID: 29246359 [No Abstract] [Full Text] [Related]
2. Frances Kelsey honored for FDA legacy: award notes her work on thalidomide, clinical trials. Kuehn BM JAMA; 2010 Nov; 304(19):2109-10, 2112. PubMed ID: 21081717 [No Abstract] [Full Text] [Related]
3. The courage of one's convictions: the due diligence of Frances Oldham Kelsey at the FDA. Scheindlin S Mol Interv; 2011 Feb; 11(1):3-9. PubMed ID: 21441115 [No Abstract] [Full Text] [Related]
4. Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act. Wax PM Ann Intern Med; 1995 Mar; 122(6):456-61. PubMed ID: 7856995 [TBL] [Abstract][Full Text] [Related]
5. Frances Oldham Kelsey. FDA medical reviewer leaves her mark on history. Bren L FDA Consum; 2001; 35(2):24-9. PubMed ID: 11444245 [No Abstract] [Full Text] [Related]
6. The Need for Pediatric Drug Development. Ward RM; Benjamin DK; Davis JM; Gorman RL; Kauffman R; Kearns GL; Murphy MD; Sherwin CMT J Pediatr; 2018 Jan; 192():13-21. PubMed ID: 28942898 [No Abstract] [Full Text] [Related]
7. Show drugs work before selling them. Sipp D; McCabe C; Rasko JE Nature; 2017 Mar; 543(7644):174-175. PubMed ID: 28277530 [No Abstract] [Full Text] [Related]
9. Cancer drug approval in the United States, Europe, and Japan. Milsted RA Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686 [No Abstract] [Full Text] [Related]
10. Therapeutic disasters that hastened safety testing of new drugs. Paine MF Clin Pharmacol Ther; 2017 Apr; 101(4):430-434. PubMed ID: 28318023 [TBL] [Abstract][Full Text] [Related]
11. The role of the fDA in cancer clinical trials. Hirschfeld S Cancer Treat Res; 2007; 132():51-109. PubMed ID: 17305017 [No Abstract] [Full Text] [Related]
14. Sam Greenhouse: his contributions as a consultant to the Food and Drug Administration. O'Neill RT Stat Med; 2003 Nov; 22(21):3285-9. PubMed ID: 14566912 [TBL] [Abstract][Full Text] [Related]
15. Access before approval--a right to take experimental drugs? Okie S N Engl J Med; 2006 Aug; 355(5):437-40. PubMed ID: 16885545 [No Abstract] [Full Text] [Related]
16. Unintended Consequences: The Story of PERF. Elterman RD; Shields WD Pediatr Neurol; 2015 Sep; 53(3):183-4. PubMed ID: 26149106 [No Abstract] [Full Text] [Related]
17. Food and Drug Administration centennial: recognizing the guardians of our drug supply. Beary JF Arthritis Rheum; 2006 Oct; 54(10):3374. PubMed ID: 17009312 [No Abstract] [Full Text] [Related]
18. ["Just crash through it": an affirmative model of disability]. Baena Molina R Cuad Bioet; 2010; 21(73):405-18. PubMed ID: 21495239 [No Abstract] [Full Text] [Related]
19. Drug development and FDA approval, 1938-2013. Darrow JJ; Kesselheim AS N Engl J Med; 2014 Jun; 370(26):e39. PubMed ID: 24963591 [No Abstract] [Full Text] [Related]
20. Drug development history, "overview," and what are GCPs? Heilman RD Qual Assur; 1995 Mar; 4(1):75-9. PubMed ID: 8520867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]